These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
58 related articles for article (PubMed ID: 23545901)
1. GABAA receptor-binding protein promotes sensitivity to apoptosis induced by chemotherapeutic agents. Rho SB; Byun HJ; Kim BR; Kim IS; Lee JH; Yoo R; Park ST; Park SH Int J Oncol; 2013 May; 42(5):1807-14. PubMed ID: 23545901 [TBL] [Abstract][Full Text] [Related]
2. PDCD6 additively cooperates with anti-cancer drugs through activation of NF-κB pathways. Park SH; Lee JH; Lee GB; Byun HJ; Kim BR; Park CY; Kim HB; Rho SB Cell Signal; 2012 Mar; 24(3):726-33. PubMed ID: 22142513 [TBL] [Abstract][Full Text] [Related]
3. Cyclic GMP/protein kinase G type-Iα (PKG-Iα) signaling pathway promotes CREB phosphorylation and maintains higher c-IAP1, livin, survivin, and Mcl-1 expression and the inhibition of PKG-Iα kinase activity synergizes with cisplatin in non-small cell lung cancer cells. Wong JC; Bathina M; Fiscus RR J Cell Biochem; 2012 Nov; 113(11):3587-98. PubMed ID: 22740515 [TBL] [Abstract][Full Text] [Related]
4. Time-dependent changes in factors involved in the apoptotic process in human ovarian cancer cells as a response to cisplatin. Kolfschoten GM; Hulscher TM; Schrier SM; van Houten VM; Pinedo HM; Boven E Gynecol Oncol; 2002 Mar; 84(3):404-12. PubMed ID: 11855878 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate. Liang YC; Lin-Shiau SY; Chen CF; Lin JK J Cell Biochem; 1999 Oct; 75(1):1-12. PubMed ID: 10462699 [TBL] [Abstract][Full Text] [Related]
6. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway. Shan BE; Wang MX; Li RQ Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933 [TBL] [Abstract][Full Text] [Related]
7. Mechanisms involved in resveratrol-induced apoptosis and cell cycle arrest in prostate cancer-derived cell lines. Benitez DA; Pozo-Guisado E; Alvarez-Barrientos A; Fernandez-Salguero PM; Castellón EA J Androl; 2007; 28(2):282-93. PubMed ID: 17050787 [TBL] [Abstract][Full Text] [Related]
8. Dual apoptotic effect of Xrel3 c-Rel/NF-kappaB homolog in human cervical cancer cells. Shehata M; Shehata M; Shehata F; Pater A Cell Biol Int; 2004; 28(12):895-904. PubMed ID: 15566959 [TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor binding protein-3 induces G1 cell cycle arrest with inhibition of cyclin-dependent kinase 2 and 4 in MCF-7 human breast cancer cells. Kim HS; Lee WJ; Lee SW; Chae HW; Kim DH; Oh Y Horm Metab Res; 2010 Mar; 42(3):165-72. PubMed ID: 19960406 [TBL] [Abstract][Full Text] [Related]
10. Bcl-2 and CCND1/CDK4 expression levels predict the cellular effects of mTOR inhibitors in human ovarian carcinoma. Aguirre D; Boya P; Bellet D; Faivre S; Troalen F; Benard J; Saulnier P; Hopkins-Donaldson S; Zangemeister-Wittke U; Kroemer G; Raymond E Apoptosis; 2004 Nov; 9(6):797-805. PubMed ID: 15505422 [TBL] [Abstract][Full Text] [Related]
11. Tumor suppressor BLU promotes paclitaxel antitumor activity by inducing apoptosis through the down-regulation of Bcl-2 expression in tumorigenesis. Park ST; Byun HJ; Kim BR; Dong SM; Park SH; Jang PR; Rho SB Biochem Biophys Res Commun; 2013 May; 435(1):153-9. PubMed ID: 23628417 [TBL] [Abstract][Full Text] [Related]
12. Enhancement of hypoxia-induced apoptosis of human breast cancer cells via STAT5b by momilactone B. Joung YH; Lim EJ; Kim MS; Lim SD; Yoon SY; Lim YC; Yoo YB; Ye SK; Park T; Chung IM; Bae KY; Yang YM Int J Oncol; 2008 Sep; 33(3):477-84. PubMed ID: 18695876 [TBL] [Abstract][Full Text] [Related]
13. Protein kinase C delta inhibits Caco-2 cell proliferation by selective changes in cell cycle and cell death regulators. Cerda SR; Mustafi R; Little H; Cohen G; Khare S; Moore C; Majumder P; Bissonnette M Oncogene; 2006 May; 25(22):3123-38. PubMed ID: 16434969 [TBL] [Abstract][Full Text] [Related]
14. Enhancing cisplatin sensitivity in MCF-7 human breast cancer cells by down-regulation of Bcl-2 and cyclin D1. Yde CW; Issinger OG Int J Oncol; 2006 Dec; 29(6):1397-404. PubMed ID: 17088977 [TBL] [Abstract][Full Text] [Related]
15. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance. Brenes O; Arce F; Gätjens-Boniche O; Díaz C Biomed Pharmacother; 2007 Jul; 61(6):347-55. PubMed ID: 17399942 [TBL] [Abstract][Full Text] [Related]
16. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems. Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971 [TBL] [Abstract][Full Text] [Related]
17. Azacitidine improves antitumor effects of docetaxel and cisplatin in aggressive prostate cancer models. Festuccia C; Gravina GL; D'Alessandro AM; Muzi P; Millimaggi D; Dolo V; Ricevuto E; Vicentini C; Bologna M Endocr Relat Cancer; 2009 Jun; 16(2):401-13. PubMed ID: 19153211 [TBL] [Abstract][Full Text] [Related]
18. Obatoclax, a BH3 Mimetic, Enhances Cisplatin-Induced Apoptosis and Decreases the Clonogenicity of Muscle Invasive Bladder Cancer Cells via Mechanisms That Involve the Inhibition of Pro-Survival Molecules as Well as Cell Cycle Regulators. Steele TM; Talbott GC; Sam A; Tepper CG; Ghosh PM; Vinall RL Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30875757 [TBL] [Abstract][Full Text] [Related]
19. Effect of combining epidermal growth factor receptor inhibitors and cisplatin on proliferation and apoptosis of oral squamous cell carcinoma cells. Takaoka S; Iwase M; Uchida M; Yoshiba S; Kondo G; Watanabe H; Ohashi M; Nagumo M; Shintani S Int J Oncol; 2007 Jun; 30(6):1469-76. PubMed ID: 17487368 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of mTOR enhances chemosensitivity in hepatocellular carcinoma. Tam KH; Yang ZF; Lau CK; Lam CT; Pang RW; Poon RT Cancer Lett; 2009 Jan; 273(2):201-9. PubMed ID: 18824293 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]